Metastatic pancreatic cancer
Conditions
Interventions
To receive a 30-minite intravenous infusion of nab-paclitaxel at a dose of 125 mg per square meter, followed by an infusion of gemcitabine at a dose of 1000 mg per square meter for standard group, on
Sponsors
Kindai University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Histologically or cytologically confirmed adenocarcinoma of the pancreas 2)Metastatic pancreatic cancer 3)Case that is measurable. Imaging examination is finished within 4 weeks. 4)Case that chemotherapy or radiation had not been performed. 5)More than 65-years-old 6)Performance Status 0 or 1 7)Case without major organ disorders 8)Case without abnormality on ECG within 4 weeks 9)Obtain informed concent
Exclusion criteria
Exclusion criteria: 1)Pulmonary fibrosis/pneumonia interstitialis 2)Serous diarrhea 3)Active infection 4)Serious complication 5)modelate or severe pleural effusion/ascites 6)Brain metastasis with sympsons 7)Active multiple primary cancer 8)Use of warfarin potassium 9)During pregnancy 10)Serious mental disorders 11)The other inappropriate case
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response rate | — |
Countries
Japan
Contacts
Public ContactKen Kamata
Kindai University Gastroenterology and Hepatology
Outcome results
None listed